Shalini Sharp, CFO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 12,000 shares at $101.03 ($1.2M) on 2015-12-10, disclosed to the SEC on 2015-12-14.
Scheduled sale ($1.2M) by CFO & Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.03 | 5,277 | $533K | 43.7% |
| 2 | $102.16 | 6,723 | $687K | 56.3% |
| Total | $101.66 avg | 12,000 | $1.2M | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |